FINWIRES · TerminalLIVE
FINWIRES

モルガン・スタンレーは、Etsyは成長軌道に戻ったものの、持続可能性に関する疑問に直面していると指摘した。

By

-- モルガン・スタンレーは木曜日に発表したレポートの中で、Etsy(ETSY)の2026年上半期の商品総売上高(GMS)が再び一桁台半ばの成長率に回復したものの、その勢いが持続するかどうかは依然として不透明だと指摘した。 レポートによると、第1四半期のGMSは前年同期比5.5%増となり、同社は第2四半期の成長率を3~5%と見込んでいる。これは「2021年以来初めて」一桁台半ばの成長率への回帰となる。 同投資銀行は、コホートデータを見ると安定化の兆しが見られ、「常連客」と「リピーター」の数は以前の減少の後、前期比で横ばいとなり、解約率の低下、顧客獲得コストの緩和、顧客一人当たりのGMSの改善が見られると述べ、さらに「マーケティング効率」も向上していると付け加えた。 しかし、最近の成長の多くは、価格設定、好ましいマクロ経済動向、為替変動、比較の容易化といった「一時的な」要因によるものである可能性があり、中期的にGMS(流通市場規模)は引き続き一桁台前半の成長率で推移するとモルガン・スタンレーは述べている。 モルガン・スタンレーは、収益性の向上とアクティブバイヤーの純増が継続するとの見通しに基づき、2026年と2027年のGMS予測を約2%、EBITDA(金利・税金・減価償却費控除前利益)予測を約5%引き上げた。 また、リスクとリターンのバランスが取れているとして、Etsyの目標株価を60ドルから64ドルに引き上げ、投資判断は「イコールウェイト」を維持した。

Price: $64.09, Change: $-5.51, Percent Change: -7.92%

Related Articles

Research

Research Alert: The Clorox Company Beats Estimates Driven By Household And International

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:CLX reported Q3 FY 26 net sales of $1.67B, flat Y/Y with organic sales down 1%, while adj. EPS of $1.64 grew 13% and beat consensus by $0.10. Gross margin contracted 140 bps to 43.2% due to elevated manufacturing costs and unfavorable mix, though disciplined expense management supported earnings. Mixed segment performance showed Household and International delivering growth of 3% and 8%, respectively, while Lifestyle declined 9% on lower consumption and inventory adjustments. Management updated FY 26 guidance expecting net sales to decline ~6% with organic sales down ~9%, including a 7.5%-pt ERP headwind. Adj. EPS guidance of $5.45-$5.65 represents a 27%-29% decline, with gross margin expected to contract 250-300 bps from GOJO inventory step-up and elevated energy costs. The April 1 GOJO acquisition expands the health portfolio though near-term integration costs pressure results. We believe the completed $580M digital transformation positions CLX for long-term operational improvements despite macro headwinds.

$CLX
Research

Research Alert: Rivn: Q1 Eps Ahead Of Consensus; 2026 Guidance Unchanged

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Rivian (RIVN) posted Q1 adjusted EPS of -$0.55 vs. -$0.41, ahead of the -$0.60 consensus. Revenue rose 11% to $1.38B ($10M ahead of consensus) on a 20% increase in total vehicle sales to 10,365 units, augmented by a 49% Y/Y increase in software and services revenue to $473M. RIVN's gross margin contracted 800 bps to 8.6%, but was ahead of the 8.4% consensus. The quarter's financial results reflect the company's strategic pivot toward broader market accessibility with the R2, though at the cost of near-term profitability. RIVN maintained prior 2026 guidance for adjusted EBITDA, vehicle deliveries, and capex. The company ended Q1 with cash of $4.8B, down from $6.1B at year-end 2025. Shares are trading 1% higher in after-hours trading. RIVN's Q1 earnings were ahead of expectations, although cash burn remains a key concern, with free cash flow deteriorating, driven by increased operating expenses and working capital consumption. Execution risks remain high given challenging demand facing the broader EV industry.

$RiVN
Australia

Tanger Q1 Core FFO, Revenue Rise; 2026 Guidance Increased

Tanger (SKT) reported Q1 core funds from operations late Thursday of $0.59 per diluted share, up from $0.53 a year earlier.Analysts polled by FactSet expected $0.58.Revenue in the three months ended March 31 rose to $150.4 million from $135.4 million a year earlier.Analysts surveyed by FactSet expected $142.9 million.The company raised 2026 FFO guidance to $2.42 to $2.50 per diluted share from $2.41 to $2.49.Analysts polled by FactSet expect $2.47.Tanger shares fell 2.3% in after-hours trading.

$SKT